NCT05027230View on ClinicalTrials.gov

A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

July 15, 2023

Study Completion Date

July 29, 2023

Conditions
Hemophilia
Interventions
DRUG

STSP-0601 for Injection

A multiple-dose design to evaluate the safety,tolerability and efficacy of two doses of STSP-0601 for injection in patients with inhibitory hemophilia

DRUG

STSP-0601 for Injection

A multiple-dose design to evaluate the safety,tolerability and efficacy of two doses of STSP-0601 for injection in patients with inhibitory hemophilia

Trial Locations (1)

300020

Hospital of Hematology, Chinese Academy of Medical Sciences, Tianjin

All Listed Sponsors
lead

Staidson (Beijing) Biopharmaceuticals Co., Ltd

INDUSTRY

NCT05027230 - A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor | Biotech Hunter | Biotech Hunter